| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005853A1 TREATMENT OF IgA NEPHROPATHY |
| 02/29/1996 | WO1996005852A1 Treatment of inflammatory diseases of the gastro-intestinal tract |
| 02/29/1996 | WO1996005847A1 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 02/29/1996 | WO1995032735A3 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
| 02/29/1996 | CA2198219A1 Human chemokine polypeptides |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | CA2197577A1 Immunoconjugates comprising tyrosine kinase inhibitors |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | CA2197493A1 A method of sequencing proteins by epitope ordering and protein restriction mapping |
| 02/29/1996 | CA2196997A1 Glutamate receptor |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2174534A1 Recombinant dnase b derived from streptococcus pyogenes |
| 02/28/1996 | EP0698212A1 Methods of using antibodies against human luteinizing hormone-related determinants |
| 02/28/1996 | EP0698117A1 Monoclonal antibodies against ck-mb |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
| 02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
| 02/28/1996 | EP0698037A1 Separation of anti-metal chelate antibodies |
| 02/28/1996 | EP0697906A1 Artificial receptors, antibodies, and enzymes |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117526A Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant hepatitus B virus surface antigen |
| 02/27/1996 | US5495002 Tumor associated monoclonal antibody 123AV16 |
| 02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/27/1996 | US5494802 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 02/27/1996 | US5494792 Kainate-binding, human CNS receptors of the EAA2 family |
| 02/27/1996 | US5494791 Monoclonal antibodies against glycated low density lipoprotein |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/27/1996 | US5494670 Method of treating ketosis |
| 02/22/1996 | WO1996005309A2 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 02/22/1996 | WO1996005231A1 Peptides and antibodies and their use in treatment of carcinomas |
| 02/22/1996 | WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 02/22/1996 | WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005226A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996004933A2 Cck antibodies used to improve feed efficiency |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004925A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 02/22/1996 | WO1996004790A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2196594A1 Use of antibodies to cck to improve feed efficiency |
| 02/21/1996 | EP0697111A1 Cell test for alzheimer's disease |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/20/1996 | US5493009 Antiidiotypic monoclonal antibodies MK2-23 anti-melanomal antibody 763.74 |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492839 Immunogenic ryanodine derivative and related uses |
| 02/20/1996 | US5492821 Diagnostics, food industry |
| 02/20/1996 | US5492812 Diagnostic method for Alzheimer's disease by screening for tau-peptides in the blood of a patient |
| 02/20/1996 | US5492807 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/15/1996 | WO1996004557A2 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004379A1 Methods and compositions for the expression of a bone and prostate derived growth factor |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004312A1 Small cell lung carcinoma peptides and binding agents |
| 02/15/1996 | WO1996004311A1 Monoclonal antibody to nitrotyrosine, methods for diagnosis and methods for treatment of disease |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | WO1996004305A1 Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions |
| 02/15/1996 | WO1996004302A1 Novel tumor marker for lung cancer |
| 02/15/1996 | WO1996004011A2 Novel compound to mimic a naturally occurring peptide's effect |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1995034650A3 Mn gene and protein |
| 02/15/1996 | CA2196679A1 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
| 02/14/1996 | EP0696596A1 Detection, assay and isolation of compounds having the taxane ring skeleton |
| 02/14/1996 | EP0696325A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
| 02/14/1996 | EP0696322A1 METHODS AND COMPOSITIONS FOR $i(SALMONELLA)-BASED VACCINES |
| 02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 02/14/1996 | EP0696290A1 Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
| 02/14/1996 | EP0389538B1 yETHOD OF PURIFYING RECOMBINANT t-PA FROM CORRESPONDING HOST CELL PROTEINS |
| 02/14/1996 | CN1116548A Polyclonal antibody, preparing process and use thereof |
| 02/13/1996 | US5491219 Magnetic responsiveness |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5491071 Labels; test kits; immunoassays |